Page last updated: 2024-09-05

anidulafungin and camostat

anidulafungin has been researched along with camostat in 1 studies

Compound Research Comparison

Studies
(anidulafungin)
Trials
(anidulafungin)
Recent Studies (post-2010)
(anidulafungin)
Studies
(camostat)
Trials
(camostat)
Recent Studies (post-2010) (camostat)
568333313371493

Protein Interaction Comparison

ProteinTaxonomyanidulafungin (IC50)camostat (IC50)
Transmembrane protease serine 2Homo sapiens (human)0.018
ProthrombinHomo sapiens (human)0.399
Serine protease hepsinHomo sapiens (human)0.0235
Trypsin-1Homo sapiens (human)0.0035
Trypsin-2Homo sapiens (human)0.0035
Procathepsin LHomo sapiens (human)0.018
FurinHomo sapiens (human)0.018
Trypsin-3Homo sapiens (human)0.0035
Transmembrane protease serine 6Homo sapiens (human)0.018
Multidrug and toxin extrusion protein 1Homo sapiens (human)2.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D1

Other Studies

1 other study(ies) available for anidulafungin and camostat

ArticleYear
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
    Antimicrobial agents and chemotherapy, 2020, 06-23, Volume: 64, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells

2020